bcl-2, p53, and response to tamoxifen in estrogen receptor-positive metastatic breast cancer: a Southwest Oncology Group study

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
R M ElledgeC K Osborne

Abstract

To test the hypothesis that high bcl-2 expression and accumulation of p53 protein, both of which should inhibit apoptosis, are associated with a poorer tamoxifen response and a more aggressive clinical course in estrogen receptor (ER)-positive metastatic breast cancer. A total of 205 paraffin-embedded tumor blocks were evaluated for nuclear p53 (a marker of p53 inactivation) and cytoplasmic bcl-2 by immunohistochemistry (IHC). All patients received tamoxifen as initial therapy for metastatic disease. The study began in 1982 and follow-up duration of the 24 patients last known alive is 8 years. Response to tamoxifen and time to treatment failure (TTF) were not significantly associated with p53 status, although patients with higher p53 had a worse survival (P = .008; median, 36 v 20 months). Higher bcl-2 expression was associated with higher levels of ER (P = .02), better response to tamoxifen (62% v 49%; P = .07), longer TTF (median, 9 v 5 months; P = .002), and better survival (median, 40 months v 25 months; P = .009). In multivariate analyses, including ER, progesterone receptor (PgR), and p53, high bcl-2 remained significantly associated with a longer TTF (P = .007) and survival (P = .07). p53 status was a significant factor ...Continue Reading

Citations

Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S C TangN Shaheta
Aug 6, 1999·Cancer Investigation·A Lupulescu
Mar 29, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·K Mokbel, A C Leris
Mar 6, 2003·Journal of the National Cancer Institute·C Kent OsborneRachel Schiff
Nov 6, 2007·Breast Cancer Research : BCR·Alison J ButtElizabeth A Musgrove
Oct 22, 2008·Breast Cancer Research : BCR·Julie A VendrellPascale A Cohen
Mar 15, 2011·Breast Cancer Research and Treatment·L KastlA C Schofield
Jan 25, 2013·Journal of breast cancer·Han-Sung KimYoung-Duck Kim
Nov 2, 2001·Breast Cancer Research and Treatment·E ScarpiD Amadori
Mar 1, 2002·British Journal of Cancer·G Pérez-TenorioUNKNOWN Southeast Sweden Breast Cancer Group
Aug 12, 2003·Breast Cancer Research and Treatment·Ida R K BukholmGeir Bukholm
Feb 28, 2008·Applied Immunohistochemistry & Molecular Morphology : AIMM·Aziza NassarCynthia Cohen
Jan 5, 2014·PloS One·Emer CaffreyGrace Callagy
Jan 11, 2018·Reviews in the Neurosciences·Sara HanaeiNima Rezaei
Jul 18, 2000·International Journal of Cancer. Journal International Du Cancer·R SilvestriniM G Daidone
Dec 27, 2007·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·A Urruticoechea
Nov 24, 1999·International Journal of Cancer. Journal International Du Cancer·M G DaidoneR Silvestrini
Oct 5, 2010·Medical Oncology·Imen Kallel-BayoudhAhmed Rebaï
Aug 3, 2018·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Andreas U LindnerJochen H M Prehn
Aug 13, 2017·Medical Oncology·Carla Solange Escórcio-DouradoBenedito Borges da Silva
Jul 17, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A S KnoopC Rose
Jan 8, 1999·Breast Cancer Research and Treatment·M F El EtrebyP V Schoenlein
May 31, 2008·BMC Cancer·Grace M CallagyCarlos Caldas

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Related Papers

European Journal of Gynaecological Oncology
L G dos SantosB B da Silva
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
C K OsborneMark Sellers
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Matthew P GoetzFergus J Couch
© 2021 Meta ULC. All rights reserved